Modern Healthspan: CRISPR Therapy: Silencing PCSK9 Gene for Heart Health #shorts
M Modern Healthspan Video Summary · February 9, 2026 View Full Protocol → Key Takeaways CRISPR-based PCSK9 therapy is in human trials for cardiovascular disease prevention. This approach epigenetically silences PCSK9 rather than blocking the protein like current drugs. Potential for one-time treatment instead of daily PCSK9 inhibitor medications. Phase 1 trial focuses on safety…
